Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required)

0 Saves · 0 Shares · 0 Comments Discussion

Grant Name

Funder

National Institutes of Health (NIH)

Department of Health and Human Services (HHS)

Country or Region

United States

Research Field

Health

Deadline

Jul 12, 2023 12:00:00 AM EDT

Grant Size

$325,000

Contact Info

National Institutes of Health OERWebmaster03@od.nih.gov

Eligibility

Eligible Applicants:

Small businesses

Additional Information on Eligibility:

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

Grant Number

RFA-TR-22-029

Description

The purpose of this Funding Opportunity Announcement (FOA) is to support basket clinical trials of drugs targeting shared molecular etiologies in more than one rare disease. To facilitate clinical trial start up, and leverage existing datasets, preference will be given to applications focusing on diseases that are under study by the Rare Disease Clinical Research Network (RDCRN), and that involve collaborations with RDCRN clinical investigators.

Website

http://grants.nih.gov/grants/guide/rfa-files/RFA-TR-22-029.html

Funding resources
Purdue Grant Writing Lab: Introduction to Grant Writing	Open Link
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal	Open Link